-
1
-
-
84928580276
-
Studies on prostate cancer: I. The effect of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate
-
Huggins C., and Hodges C.V. Studies on prostate cancer: I. The effect of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1 (1941) 293-297
-
(1941)
Cancer Res
, vol.1
, pp. 293-297
-
-
Huggins, C.1
Hodges, C.V.2
-
2
-
-
0034659787
-
Hormone therapy for patients with prostate carcinoma
-
Klotz L. Hormone therapy for patients with prostate carcinoma. Cancer 88 (2000) 3009-3014
-
(2000)
Cancer
, vol.88
, pp. 3009-3014
-
-
Klotz, L.1
-
3
-
-
0142248845
-
Variables in predicting survival based on treating "PSA-only" relapse
-
Moul J.W. Variables in predicting survival based on treating "PSA-only" relapse. Urol Oncol 21 (2003) 292-304
-
(2003)
Urol Oncol
, vol.21
, pp. 292-304
-
-
Moul, J.W.1
-
5
-
-
0033540004
-
Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer
-
Messing E.M., Manola J., Sarosdy M., et al. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341 (1999) 1781-1788
-
(1999)
N Engl J Med
, vol.341
, pp. 1781-1788
-
-
Messing, E.M.1
Manola, J.2
Sarosdy, M.3
-
6
-
-
0031403675
-
Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial
-
The Medical Research Council Prostate Cancer Working Party Investigators Group
-
The Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial. Br J Urol 79 (1997) 235-246
-
(1997)
Br J Urol
, vol.79
, pp. 235-246
-
-
-
7
-
-
0037298718
-
National Comprehensive Cancer Network guidelines for the management of prostate cancer
-
Scherr D., Swindle P.W., and Scardino P.T. National Comprehensive Cancer Network guidelines for the management of prostate cancer. Urology 61 (2003) 14-24
-
(2003)
Urology
, vol.61
, pp. 14-24
-
-
Scherr, D.1
Swindle, P.W.2
Scardino, P.T.3
-
8
-
-
0030827106
-
Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer
-
Zagars G.K., and Pollack A. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol 44 (1997) 213-221
-
(1997)
Radiother Oncol
, vol.44
, pp. 213-221
-
-
Zagars, G.K.1
Pollack, A.2
-
9
-
-
0033526309
-
Natural history of progression after PSA elevation following radical prostatectomy
-
Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 281 (1999) 1591-1597
-
(1999)
JAMA
, vol.281
, pp. 1591-1597
-
-
Pound, C.R.1
Partin, A.W.2
Eisenberger, M.A.3
-
10
-
-
0028198996
-
Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: Early versus delayed treatment
-
McCarthy J.F., Catalona W.J., and Hudson M.A. Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: Early versus delayed treatment. J Urol 151 (1994) 1575-1578
-
(1994)
J Urol
, vol.151
, pp. 1575-1578
-
-
McCarthy, J.F.1
Catalona, W.J.2
Hudson, M.A.3
-
11
-
-
0036603607
-
Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer
-
Hanlon A.L., Diratzouian H., and Hanks G.E. Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer. Int J Radiat Oncol Biol Phys 53 (2002) 297-303
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.53
, pp. 297-303
-
-
Hanlon, A.L.1
Diratzouian, H.2
Hanks, G.E.3
-
12
-
-
0031014008
-
Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations
-
Lee W.R., Hanks G.E., and Hanlon A. Increasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: Clinical observations. J Clin Oncol 15 (1997) 230-238
-
(1997)
J Clin Oncol
, vol.15
, pp. 230-238
-
-
Lee, W.R.1
Hanks, G.E.2
Hanlon, A.3
-
13
-
-
0027202228
-
Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling time
-
Hanks G.E., D'Amico A., Epstein B.E., et al. Prostatic-specific antigen doubling times in patients with prostate cancer: A potentially useful reflection of tumor doubling time. Int J Radiat Oncol Biol Phys 27 (1993) 125-127
-
(1993)
Int J Radiat Oncol Biol Phys
, vol.27
, pp. 125-127
-
-
Hanks, G.E.1
D'Amico, A.2
Epstein, B.E.3
-
14
-
-
0033973235
-
Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate
-
DeWeese T.L., and Song D.Y. Current evidence for the role of combined androgen suppression and radiation in the treatment of adenocarcinoma of the prostate. Urology 55 (2000) 169-174
-
(2000)
Urology
, vol.55
, pp. 169-174
-
-
DeWeese, T.L.1
Song, D.Y.2
-
15
-
-
0002646642
-
Androgen ablation in addition to radiation therapy for prostate cancer: Is there true benefit?
-
Pollack A., and Zagars G.K. Androgen ablation in addition to radiation therapy for prostate cancer: Is there true benefit?. Semin Radiat Oncol 8 (1998) 95-106
-
(1998)
Semin Radiat Oncol
, vol.8
, pp. 95-106
-
-
Pollack, A.1
Zagars, G.K.2
-
16
-
-
0037335351
-
Quality of life following definitive therapy for localized prostate cancer: Potential impact of multiple therapies
-
Litwin M.S. Quality of life following definitive therapy for localized prostate cancer: Potential impact of multiple therapies. Curr Opin Urol 13 (2003) 153-156
-
(2003)
Curr Opin Urol
, vol.13
, pp. 153-156
-
-
Litwin, M.S.1
-
17
-
-
0030906817
-
Consensus statement guidelines for PSA following radiation therapy
-
American Society for Therapeutic Radiation and Oncology (ASTRO)
-
American Society for Therapeutic Radiation and Oncology (ASTRO). Consensus statement guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.37
, pp. 1035-1041
-
-
-
18
-
-
0035667653
-
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium
-
Partin A.W., Mangold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58 (2001) 843-848
-
(2001)
Urology
, vol.58
, pp. 843-848
-
-
Partin, A.W.1
Mangold, L.A.2
Lamm, D.M.3
-
19
-
-
0031051097
-
Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85-31
-
Pilepich M.V., Caplan R., Byhardt R.W., et al. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: Report of Radiation Therapy Oncology Group Protocol 85-31. J Clin Oncol 15 (1997) 1013-1021
-
(1997)
J Clin Oncol
, vol.15
, pp. 1013-1021
-
-
Pilepich, M.V.1
Caplan, R.2
Byhardt, R.W.3
-
20
-
-
0030856678
-
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
-
Bolla M., Gonzalez D., Warde P., et al. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. N Engl J Med 337 (1997) 295-300
-
(1997)
N Engl J Med
, vol.337
, pp. 295-300
-
-
Bolla, M.1
Gonzalez, D.2
Warde, P.3
-
21
-
-
0032412702
-
Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: A prospective randomized study
-
Granfors T., Modig H., Damber J.E., et al. Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: A prospective randomized study. J Urol 159 (1998) 2030-2034
-
(1998)
J Urol
, vol.159
, pp. 2030-2034
-
-
Granfors, T.1
Modig, H.2
Damber, J.E.3
-
22
-
-
0028229803
-
Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer
-
Pollack A., Zagars G.K., and Kavadi V.S. Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer. Cancer 74 (1994) 670-678
-
(1994)
Cancer
, vol.74
, pp. 670-678
-
-
Pollack, A.1
Zagars, G.K.2
Kavadi, V.S.3
-
23
-
-
0034904071
-
The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: A survey of practice patterns of urologists and radiation oncologists in the United States
-
Sylvester J., Grimm P., Blasco J., et al. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: A survey of practice patterns of urologists and radiation oncologists in the United States. Urology 58 (2001) 65-70
-
(2001)
Urology
, vol.58
, pp. 65-70
-
-
Sylvester, J.1
Grimm, P.2
Blasco, J.3
-
24
-
-
12144290450
-
Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy
-
Moul J.W., Wu H., Sun L., et al. Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. J Urol 171 (2004) 1141-1147
-
(2004)
J Urol
, vol.171
, pp. 1141-1147
-
-
Moul, J.W.1
Wu, H.2
Sun, L.3
|